Skip to content

Clinical trials

Breast Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Germany Clear all

630 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20019
200213
200321
200415
200515
200627
200724
200814
200925
201021
201124
201235
201333
201430
201524
201622
201723
201824
201924
202025
202131
202229
202332
202425
202532
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed361
Recruiting92
Active, not recruiting75
Terminated54
Unknown status35
Withdrawn5
Not yet recruiting4
Approved for marketing2
Suspended1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche57
Novartis Pharmaceuticals53
AstraZeneca36
Eli Lilly and Company26
GBG Forschungs GmbH26
Pfizer23
Women's Cancer Study Group GmbH17
European Organisation for Research and Treatment of Cancer - EORTC11
Bayer10
GlaxoSmithKline10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms630
Neoplasm Metastasis51
Neoplasms43
Colorectal Neoplasms22
Ovarian Neoplasms22
Carcinoma, Non-Small-Cell Lung19
Lung Neoplasms19
Prostatic Neoplasms19
Triple Negative Breast Neoplasms19
Pancreatic Neoplasms12

Trials

Showing 1 to 25 of 630. Each trial links to its page on Pharma Observatory.

530 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.